CR Double-Crane Pharmaceutical Obtains Drug Registration for Contrast Agent

MT NewswiresMar 26 13:37

Express News | China Resources Double-Crane Pharmaceutical: Gadobutrol injection has obtained the Pharmaceutical registration certificate.

BreakingsMar 25 16:44

China Resources Double-Crane Pharmaceutical (600062): Continuous upgrading of infusion packaging materials, with Yuting leading specialized growth.

In 2024, the company achieved revenue of 11.21 billion yuan (-0.87% year-on-year) and a net income of 1.63 billion yuan (-2.55% year-on-year). In Q4 2024, the decline in revenue and profit slightly expanded, mainly due to large-volume infusion.

HTSCMar 20 10:52

CR Double-Crane Pharmaceutical 2024 Profit Down 3%; Shares Decline 3%

MT NewswiresMar 20 10:23

China Resources Pharma (03320.HK) subsidiary China Resources Double-Crane Pharmaceutical earned 1.628 billion RMB last year, a decrease of 2.6%.

CHINARES PHARMA (03320.HK) announced that its subsidiary China Resources Double-Crane Pharmaceutical's revenue for the fiscal year 2024 was 11.212 billion yuan, a slight decrease of 0.9% year-on-year. The net profit attributable to shareholders was 1.628 billion yuan, a decline of 2.6%.

AASTOCKSMar 20 00:30

China Resources Shuanghe: Summary of China Resources Shuanghe 2024 Annual Report

SZSIMar 20 00:00 · Announcements